Akorn Overview

  • Founded
  • 1971

  • Status
  • Public

  • Employees
  • 2,000

  • Stock Symbol
  • FDA

Stock Symbol
  • Investments
  • 13

Akorn General Information


Akorn Inc is a pharmaceutical company. It is engaged in the development, manufacturing, and marketing of generic and prescription pharmaceuticals. The firm has two segments namely Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals including sterile ophthalmics, injectables, and inhalants, and non-sterile oral liquids, topicals and nasal sprays whereas the Consumer Health segment consist of animal health and over-the-counter products, both branded and private-label. The company generates a majority of its revenue from the Prescription Pharmaceuticals segment.

Contact Information

Formerly Known As
Akorn Ophthalmics
Ownership Status
Publicly Held
Financing Status
Primary Industry
Other Industries
Distributors (Healthcare)
Drug Discovery
Stock Exchange
Primary Office
  • 1925 West Field Court
  • Suite 300
  • Lake Forest, IL 60045
  • United States
+1 (800) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Akorn Financials Summary

In Thousands,
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
Revenue 663,504 682,429 694,018 841,045
EBITDA (315,105) (148,125) (309,477) 64,045
Net Income (358,379) (226,770) (401,909) (24,550)
Total Assets 1,001,764 1,288,639 1,495,257 1,909,511
Total Debt 885,647 867,639 820,411 815,195
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Akorn Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Akorn‘s full profile, request access.

Request a free trial

Akorn Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Akorn Inc is a pharmaceutical company. It is engaged in the development, manufacturing, and marketing of generic and pre
Lake Forest, IL
2,000 As of 2018


fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia de
Bridgewater, NJ
0000 As of 0000
000000 - 000 00.000

0000 0

e magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip e
Haifa Bay, Israel
0000 As of 0000
0.000 0000-00-00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Akorn Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amneal Pharmaceuticals Formerly PE-Backed Bridgewater, NJ 0000 00.000 000000 - 000 00.000
0000 0000000000000 Corporate Backed or Acquired Haifa Bay, Israel 0000 0000 00000000000
000 00000000000000 Corporation Baudette, MN 000 00000 000000000 00000
000000000000000 00 Corporation Lagos, Nigeria 00
00000 Corporation Mumbai, India 00000 00000000
You’re viewing 5 of 25 competitors. Get the full list »

Akorn Patents

Akorn Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10426834-B1 Methods of sterilizing drugs Active 11-Aug-2016 000000000 0
US-9517269-B1 Stable pentobarbital formulation Active 01-Oct-2013 000000000
US-20090123527-A1 Method of inducing topical anesthesia and transdermal patch Abandoned 24-Jul-2006 0000000000
US-20050249820-A1 Nutritional supplement for the treatment and prevention of macular degeneration Abandoned 04-May-2004 000000000 0
US-20040186084-A1 Sterile aqueous composition comprising triamcinolone acetonide, and tonicity-adjusting agents, ph-adjusting agents to provide a ph of between about 5 and 7.5; treating diabetic macular edema and related illness; intravitreal injection Abandoned 21-Mar-2003 A61K31/58
To view Akorn’s complete patent history, request access »

Akorn Executive Team (20)

Name Title Board Seat Contact Info
Mark Silverberg Executive Vice President, Operations, Global Quality Assurance & Technical Services
John Kapoor Ph.D Founder
Jennifer Bowles Senior Vice President & General Manager, Branded Ophthalmics
Randall Pollard Chief Accounting Officer
Beth Kaufman Executive Vice President, Chief Legal Officer & Corporate Secretary
You’re viewing 5 of 20 executive team members. Get the full list »

Akorn Board Members (5)

Name Representing Role Since
0000 000000 00.0 Self Founder 000 0000
You’re viewing 1 of 5 board members. Get the full list »

Akorn Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Akorn Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Akorn‘s full profile, request access.

Request a free trial

Akorn Investments & Acquisitions (13)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 02-Jan-2015 0000000000 000.00 Therapeutic Devices
0000000 30-Sep-2014 0000000000 0000 Pharmaceuticals 00000 000
0000000000 12-Aug-2014 0000000000 00000 Pharmaceuticals 00000 000
00-0000 00000 17-Apr-2014 0000000000 00000 Pharmaceuticals 00000 000
BETIMOL 02-Jan-2014 Corporate Asset Purchase 00000 Buildings and Property 00000 000
You’re viewing 5 of 13 investments and acquisitions. Get the full list »

Akorn Subsidiaries (1)

Company Name Industry Location Founded
00-0000 000000000 Pharmaceuticals Amityville, NY 0000
To view Akorn’s complete subsidiaries history, request access »

Akorn Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 00000000000 11-Aug-2011 00000 00000 00 000 Completed
  • 5 buyers
TheraTears 03-May-2011 Merger/Acquisition 000.00 Completed
To view Akorn’s complete exits history, request access »